Loading...

LifeMD, Inc.

LFMDNASDAQ
Healthcare
Medical - Pharmaceuticals
$13.07
$-0.55(-4.04%)

LifeMD, Inc. LFMD Peers

See (LFMD) competitors and their performances in Stock Market.

Peer Comparison Table: Medical - Pharmaceuticals Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
LFMD$13.07-4.04%596.7M-39.79-$0.33N/A
ONC$243.67+0.66%24.4B-67.54-$3.63N/A
INSM$97.15-3.47%18.5B-16.43-$5.94N/A
WBA$11.48+0.03%9.9B-1.58-$7.29+4.36%
HROWL$25.50-0.08%1.2BN/AN/AN/A
HROWM$26.44+0.42%1.1BN/AN/A+11.20%
LFMDP$24.25+0.17%1.1B-10.75-$2.26N/A
HITI$2.32+1.07%186.4M-25.56-$0.09N/A
PETS$3.28-1.20%67.5M327.00$0.01N/A
YI$7.09-0.78%61.6M-3.27-$2.17N/A
Showing 1 to 10 of 21 results
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

LFMD vs ONC Comparison

LFMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, LFMD stands at 596.7M. In comparison, ONC has a market cap of 24.4B. Regarding current trading prices, LFMD is priced at $13.07, while ONC trades at $243.67.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

LFMD currently has a P/E ratio of -39.79, whereas ONC's P/E ratio is -67.54. In terms of profitability, LFMD's ROE is +2.33%, compared to ONC's ROE of -0.12%. Regarding short-term risk, LFMD is less volatile compared to ONC. This indicates potentially lower risk in terms of short-term price fluctuations for LFMD.

Stock Price Comparison

Loading...

Frequently Asked Questions

;